Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-05

Clinical Trial Update: Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in Children [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of artesunate-amodiaquine-methylene for treating uncomplicated falciparum malaria in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate-amodiaquine-methylene

Snippet

Sponsor: Heidelberg University | Conditions: Uncomplicated Falciparum Malaria | Phase 2 | Status: COMPLETED